AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports Reuters

March 7, 2026 at 01:04 AM Original source
2 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
1 articles
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

C
Carlos MéndezJournalist

Carlos Méndez is a journalist reporting from Mexico City.

Locations

denmark Mexico City, Mexico USA

Tags

business partnership drugs feud health healthcare hims novo obesity obesity drugs partnership pharmaceuticals weight loss

All Coverage

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNdXNlT2JONFFqbVlvbHRJQlRZQkc4MXFjcGlobnVyYklCZzlKdnpQMkYtaUp4enVqVGNUTjZ6SWJMLW5XWjB2Wk1YZ2tMTm42Mi1pVDVYcUI4ZGRRTkJ3bWtETmxWejNHd3pqbWVjMUxMN3JCM05aa1ZoTkszNEdMUXZYc202Uk80QzFkcUNyZVJjM2ZLM01uZDNHeTlZTXlXOEFmS2Q2WWc2OG5KR3Q5M3pyQVpCYTd5M3JwclZUMVlNSE1ZeHJXc1pEelpoQ2xaQ2Rxbl9wa2pOeTM2ZFE?oc=5" target="_blank">Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%
Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports
Yahoo! Newsvia ai

Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, ending a dispute that escalated into a legal battle last month.

80%

Similar Stories

Related coverage based on topic and tags

Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com

Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com

August 13, 2026 at 10:02 AM

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com

August 12, 2026 at 10:27 AM

As Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters

As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters

August 12, 2026 at 06:34 PM

Novo begins study to find lowest effective dose for Wegovy pill - Reuters

Novo begins study to find lowest effective dose for Wegovy pill Reuters

August 19, 2026 at 03:26 PM

Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters

Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters

August 13, 2026 at 06:00 PM

Humana agrees not to reference Teva's Israel ties at US drug trial - Reuters

Humana agrees not to reference Teva's Israel ties at US drug trial Reuters

August 13, 2026 at 03:33 PM